Biotechnology Market Size, Share, Growth Analysis, and Forecast 2025–2033

The global biotechnology market.) was valued at USD 761.5 Billion in 2024 and is projected to reach USD 1,315.9 Billion by 2033, growing at a CAGR of 6.27% during the 2025-2033 forecast period. Growth is fueled by advancements in personalized medicine, genetic engineering, and increasing demand for sustainable agricultural solutions. Biotechnology impacts healthcare, agriculture, and environmental management by developing innovative products and technologies.

STUDY ASSUMPTION YEARS

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

BIOTECHNOLOGY MARKET KEY TAKEAWAYS

• The global biotechnology market size was USD 761.5 Billion in 2024.
• The market is expected to grow at a CAGR of 6.27% from 2025 to 2033.
• The forecast period for market growth extends from 2025 to 2033.
• Innovations in gene editing and personalized medicine are primary growth drivers.
• The market benefits from the rising incidence of chronic diseases, boosting biopharmaceutical demand.
• Sustainable agriculture needs, such as improving crops and biopesticides, propel market adoption.
• Bioinformatics and biofuels contribute to growth by integrating information technology and sustainability.

Sample Request Link:

https://www.imarcgroup.com/biotechnology-market/requestsample

MARKET GROWTH FACTORS

The biotechnology market is booming thanks to rapid advancements in genetic engineering, especially with the CRISPR-Cas9 technology. This innovative tool allows for precise gene modifications, leading to groundbreaking applications in medicine, agriculture, and industry. It plays a crucial role in developing gene therapies for genetic disorders and cancers, while also enhancing the microbial production of essential compounds like insulin and enzymes. The diverse applications of genetic engineering are significantly driving market growth throughout the forecast period.

A major factor in this growth is the development of personalized medicine, which uses genomic sequencing to customize treatments based on a person's unique genetic profile. This tailored approach not only boosts the effectiveness of therapies but also helps reduce side effects. Biotechnology is also pivotal in producing biopharmaceuticals, such as monoclonal antibodies and gene therapies, and it enables early disease detection through diagnostics based on genetic markers. These innovations have sparked increased demand in the healthcare sector, propelling the biotechnology market forward.

On the agricultural front, the demand for sustainable practices is rising due to global food requirements and environmental concerns. Biotechnology is key in creating genetically modified crops that offer higher yields, pest resistance, and improved nutritional value. Biopesticides, which are gentler on the environment, are becoming more popular. Moreover, biotechnology enhances crops' resilience to climate change and improves nutrient use efficiency, which is vital for food security and resource sustainability, thus significantly boosting market growth.

MARKET SEGMENTATION

Breakup by Product Type:

• Instruments: Instruments form the foundation of advanced research and diagnostics, enabling precise analysis and experimentation.
• Reagents: Reagents are essential components that fuel experimental processes, facilitating accurate results and breakthroughs.
• Software and Services: Software provides data analysis, visualization, and integration solutions enhancing efficiency; services include consulting, training, and technical support fostering collaboration and effective tool use.

Breakup by Technology:

• Nanobiotechnology: Integrates nanoscale materials with biological systems, revolutionizing drug delivery, diagnostics, and therapies.
• Tissue Engineering and Regeneration: Pioneers novel approaches for creating functional tissues, addressing organ shortages and medical needs.
• DNA Sequencing: Enables comprehensive genomic analysis guiding personalized medicine and disease understanding.
• Cell-Based Assays: Provide insights into cellular behavior, supporting drug development and toxicity testing.
• Fermentation: A cornerstone for bioprocessing, producing biofuels, pharmaceuticals, and enzymes.
• PCR Technology: Amplifies DNA, underpinning diagnostics and genetic research.
• Chromatography: Separates biomolecules with precision, crucial in drug purification and analytical processes.
• Others: Includes additional biotechnological methods beyond the specified categories.

Breakup by Application:

• Healthcare: Dominates the market as it drives innovations in diagnostics, treatments, and personalized medicine, improving outcomes and disease management.
• Food and Agriculture: Includes biotechnological enhancements in crop yield, pest resistance, and sustainability.
• Natural Resources and Environment: Biotechnological applications aimed at environmental management and sustainability.
• Industrial Processing: Use of biotechnology in manufacturing and processing industries.
• Bioinformatics: Intersection of IT and biotechnology to optimize research and data-driven development.
• Others: Additional applications not covered in primary segments.

REGIONAL INSIGHTS

North America currently dominates the biotechnology market due to its strong research ecosystem, innovation capacity, and investment in R&D. The region benefits from robust regulatory frameworks and leading universities and biotech companies pushing scientific advancements. Entrepreneurship and venture capital activity further accelerate the commercialization of biotech innovations, maintaining North America's influential role in shaping the global biotechnology landscape.

RECENT DEVELOPMENTS & NEWS

• In May 2025, Biogen and City Therapeutics partnered to develop RNA interference therapies targeting central nervous system diseases, combining an RNAi platform and delivery technology.
• In May 2025, Biocon Biologics launched Ustekinumab BS Biosimilar in Japan, expanding its global biosimilar market footprint.
• In April 2025, Novartis announced a USD 23 Billion investment over five years in the US for expanding biotech and pharmaceutical facilities.
• In April 2025, Amgen invested USD 900 Million more to expand its Ohio biologics manufacturing site, increasing jobs to 750.
• In March 2025, Roche opened the Genentech Innovation Center in Boston to lead R&D in major disease areas and AI-driven drug discovery.

KEY PLAYERS

• Amgen Inc.
• Biocon Limited
• Biogen Inc.
• F. Hoffmann-La Roche AG
• Genmab A/S
• Lonza Group AG
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc.
• Regeneron Pharmaceuticals Inc.
• Seagen Inc.
• Syngenta AG
• Vertex Pharmaceuticals Incorporated

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

ABOUT US

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

CONTACT US

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302